Company Press Release - Friday Nov. 7, 7:30 pm Eastern Time
biz.yahoo.com
Friday November 7, 7:30 pm Eastern Time
Company Press Release
SOURCE: MedCare Technologies, Inc.
Successful Expansion of the MedCare Program Continues; New Sites to Open in Arizona with
Dr. William Crisp and in Ohio with Dr. Gregory Haselhuhn
Additional Openings in Texas, Connecticut and Florida Planned Before Year End
MedCare Expands Senior Management Team with the Addition of Mr. Greg Wujek, Who Joins as Vice President of Managed
Care
NAPERVILLE, Ill., Nov. 7 /PRNewswire/ -- MedCare Technologies, Inc. (OTC Bulletin Board: MCAR - news) today announced plans to establish two
additional MedCare Program centers in Phoenix, Arizona, and in Toledo, Ohio, for the treatment of patents suffering from urinary incontinence using MedCare's
proprietary non-drug, non-surgical treatment program. The MedCare Program in Phoenix will be under the auspices of Dr. William Crisp and the Toledo program
will be in conjunction with Dr. Gregory Haselhuhn and Center Urology Associates, Inc., a multi-physician urology practice affiliated with The University of Toledo
with 6 board certified urologists and 3 offices. ''We are both excited and flattered to have such high caliber medical professionals joining our ever growing roster of
physicians throughout the nation,'' said Jeff Aronin, President and Chief Operating Officer of MedCare Technologies. ''But what we're most excited about is the
positive impact that we're making in the lives of incontinence sufferers who now have a risk free treatment option with the MedCare Program. Prior to our program,
millions of sufferers resorted to absorbent products or contended with surgical and pharmacological treatment options and their complications and side effect
profiles.''
MedCare announces the appointment of Mr. Greg Wujek as Vice President of Managed Care. Mr. Wujek has over 10 years of healthcare experience, primarily in
sales and marketing to the managed care market. Prior to joining MedCare, Mr. Wujek held the position of Vice President of Sales at SMG Marketing Group, a
consulting firm to the healthcare industry, and was a Director of Managed Care at Forest Laboratories, an international marketer of ethical pharmaceuticals. Mr.
Wujek's responsibilities at MedCare Technologies will include the development and negotiation of unique reimbursement and marketing strategies in managed care
(IPA, staff, practice management companies), long term care, integrated health networks (provider networks, physician practice management companies), hospitals,
Medicare/Medicaid, and fee for service. ''The addition of Greg Wujek to our senior management team is a significant step forward for MedCare,'' said Mr. Harmel
S. Rayat, Chairman and Chief Executive Officer of MedCare Technologies. ''People in managed care and insurance companies are intelligent and progressive
thinking. It won't take them too long to realize that significant savings are possible by placing MedCare's risk free and highly successful treatment program as a first
line treatment method rather than paying for costly conventional treatment options, such as surgery which often requires hospitalization and has potential risks and
complications.''
MedCare Technologies has developed a cost effective, non-drug, non- surgical and non-invasive system for the care and treatment of patents suffering from urinary
incontinence. MedCare's proprietary treatment protocol does not require FDA approval, is covered by most health insurance plans and results in the reduction or
complete elimination of 70% to 100% of the most commonly found urinary incontinence symptoms. Unlike traditional treatment options, which are costly and often
unsuccessful or inadequate, MedCare's treatment program is completely risk free and has a three year history with a proven success rate in excess of 85%.
MedCare Technologies offers a multi- modality program based on behavioral techniques and neuromuscular electromyography biofeedback. The MedCare
Program is designed to mobilize and strengthen various sensory-response systems and is based on operant conditioning strategies whereby specific physiological
responses are progressively shaped, strengthened and coordinated.
Numerous studies have been completed to determine the prevalence of urinary incontinence in the general population. The results of one study completed at Emory
University in Atlanta, GA, concluded that the prevalence of UI was 43.6% among women and 20.9% among men. In another study of 3,638 patients over age 20,
1908 women and 922 men completed an anonymous questionnaire. A reported 43% of women and 11% of men had current UI. Almost 75% of these patients had
not informed a health professional, but more than one third of these said they would see a physician if treatment were available. Affecting some 25 million
Americans, UI is a $16 billion market and accounts for almost half of all nursing home admissions. Despite being one of the most prevalent medical conditions in
health care today, with almost half of all women being affected at some point, UI remains a vastly under- serviced and over-looked marketplace.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are other than
statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance,
changes in technology, changes in insurance reimbursement, economic conditions, the impact of competition and pricing, government regulation, and other risks
defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether
written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which
may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or
circumstances after the date hereof.
SOURCE: MedCare Technologies, Inc.
More Quotes and News:
Medcare Tech Inc (OTC BB:MCAR - news)
Related News Categories: medical/pharmaceutical |
